Global Lipid Nanoparticles (LNP) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Lipid Nanoparticles (LNP) Market Research Report 2024
LNPs are liposome-like structures especially geared towards encapsulating a broad variety of nucleic acids (RNA and DNA); and as such, they are the most popular non-viral gene delivery system. Exelead develops and manufactures LNPs to encapsulate different types of genetic payloads including siRNA, mRNA and saRNA.
According to MRAResearch’s new survey, global Lipid Nanoparticles (LNP) market is projected to reach US$ 721.8 million in 2033, increasing from US$ 583.2 million in 2022, with the CAGR of 7.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lipid Nanoparticles (LNP) market research.
The world's core manufacturers of Lipid Nanoparticles include Merck KGaA and others. The largest manufacturer has approximately 70% of the market share. North America is the world's largest market, accounting for approximately 60% of the market, followed by Europe and Asia Pacific, accounting for 26% and 9%, respectively. Among them, mRNA-lipid nanoparticles and siRNA-lipid nanoparticles accounted for 93% and 5%, respectively. The most used are vaccine drugs and scientific research, accounting for 81% and 19% respectively.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Lipid Nanoparticles (LNP) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Segment by Type
mRNA-lipid Nanoparticle
siRNA-lipid Nanoparticle
Others
Vaccines and Drugs
Scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lipid Nanoparticles (LNP) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Lipid Nanoparticles (LNP) market is projected to reach US$ 721.8 million in 2033, increasing from US$ 583.2 million in 2022, with the CAGR of 7.3% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lipid Nanoparticles (LNP) market research.
The world's core manufacturers of Lipid Nanoparticles include Merck KGaA and others. The largest manufacturer has approximately 70% of the market share. North America is the world's largest market, accounting for approximately 60% of the market, followed by Europe and Asia Pacific, accounting for 26% and 9%, respectively. Among them, mRNA-lipid nanoparticles and siRNA-lipid nanoparticles accounted for 93% and 5%, respectively. The most used are vaccine drugs and scientific research, accounting for 81% and 19% respectively.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Lipid Nanoparticles (LNP) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Segment by Type
mRNA-lipid Nanoparticle
siRNA-lipid Nanoparticle
Others
Segment by Application
Vaccines and Drugs
Scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Lipid Nanoparticles (LNP) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source